Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study

Safety and tolerability of a cell culture derived trivalent subunit inactivated influenza vaccine administered to healthy children and adolescents: A Phase III, randomized, multicenter, observer-blind study

(2016) Terry Nolan et al.   VACCINE

Retrospective public health impact of a quadrivalent influenza vaccine in the United States

(2015) Pascal Crépey et al.   Influenza and Other Respiratory Viruses

Deaths after Fluad flu vaccine and the epidemic of panic in Italy

(2015) C. Signorelli et al.   BMJ-British Medical Journal

Deaths after Fluad flu vaccine and the epidemic of panic in Italy

(2015) C. Signorelli et al.   BMJ-British Medical Journal

4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany

(2014) Martin Eichner et al.   BMC INFECTIOUS DISEASES

Impact of Influenza B Lineage-Level Mismatch Between Trivalent Seasonal Influenza Vaccines and Circulating Viruses, 1999–2012

(2014) Terho Heikkinen et al.   CLINICAL INFECTIOUS DISEASES

Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: A phase III, randomized trial

(2014) Juan Carlos Tinoco et al.   VACCINE

Performance characteristics of qualified cell lines for isolation and propagation of influenza viruses for vaccine manufacturing

(2014) Ruben O. Donis et al.   VACCINE

The Burden of Influenza B: A Structured Literature Review

(2013) W. Paul Glezen et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults

(2013) Jiří Beran et al.   BMC INFECTIOUS DISEASES

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years

(2013) Dorothee Kieninger et al.   BMC INFECTIOUS DISEASES

Immunogenicity and safety of an inactivated 2012/2013 trivalent influenza vaccine produced in mammalian cell culture (Optaflu®)

(2013) Christof David Vinnemeier et al.   Human Vaccines & Immunotherapeutics

Immunogenicity, Safety and Reactogenicity of a Mammalian Cell-Culture–Derived Influenza Vaccine in Healthy Children and Adolescents Three to Seventeen Years of Age

(2012) Timo Vesikari et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

The economic value of a quadrivalent versus trivalent influenza vaccine

(2012) Bruce Y. Lee et al.   VACCINE

A prospective observational safety study on MF59® adjuvanted cell culture-derived vaccine, Celtura® during the A/H1N1 (2009) influenza pandemic

(2012) Humberto Reynales et al.   VACCINE

Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine

(2012) Carrie Reed et al.   VACCINE

Safety assessment and immunogenicity of a cell-culture-derived influenza vaccine in adults and elderly subjects over three successive influenza seasons

(2012) Agnieszka Szymczakiewicz-Multanowska et al.   Human Vaccines & Immunotherapeutics

The rationale for quadrivalent influenza vaccines

(2012) Christopher S. Ambrose et al.   Human Vaccines & Immunotherapeutics

Safety of MDCK cell culture-based influenza vaccines

(2011) Jens-Peter Gregersen et al.   Future Microbiology

A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults

(2011) Stan L. Block et al.   VACCINE

Clinical Efficacy of Cell Culture–Derived and Egg‐Derived Inactivated Subunit Influenza Vaccines in Healthy Adults

(2010) Sharon Frey et al.   CLINICAL INFECTIOUS DISEASES

Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example

(2009) Jiří Beran et al.   BMC INFECTIOUS DISEASES

Trivalent MDCK cell culture-derived influenza vaccine Optaflu®(Novartis Vaccines)

(2009) Alexander Doroshenko et al.   Expert Review of Vaccines

Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity

(2009) Robert B. Belshe et al.   VACCINE

Long time trends in influenza-like illness and associated determinants in The Netherlands

(2008) F. DIJKSTRA et al.   EPIDEMIOLOGY AND INFECTION

A quantitative risk assessment of exposure to adventitious agents in a cell culture-derived subunit influenza vaccine

(2008) Jens-Peter Gregersen   VACCINE